Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Helene A. Yuen"'
Autor:
Lewis R. Silverman, Weiru Hong, Maher Albitar, Alison L. Hannah, Francis J. Giles, Helene A. Yuen, Jeffrey E. Lancet, Judith E. Karp, Srdan Verstovsek, Julie M. Cherrington, Maureen Cooper, Sharianne G. Louie, Hagop M. Kantarjian, Jorge E. Cortes, Susan O'Brien, Anne Marie O'Farrell, Alison Stopeck
Publikováno v:
Blood. 102:795-801
Increased bone marrow angiogenesis and vascular endothelial growth factor (VEGF) levels are adverse prognostic features in patients with acute myeloid leukemia (AML) or myelodysplastic syndromes (MDSs). VEGF is a soluble circulating angiogenic molecu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ce110f34d5b56909fef560691bf8f3c
https://doi.org/10.1182/blood-2002-10-3023
https://doi.org/10.1182/blood-2002-10-3023
Autor:
Francis J. Giles, Beverly D. Smolich, Kristina A. West, Julie M. Cherrington, Helene A. Yuen, Maher Albitar
Publikováno v:
Blood. 97:1413-1421
SU5416 and SU6668 are potent antiangiogenic small-molecule inhibitors of receptor tyrosine kinases, including those of the vascular endothelial growth factor and platelet-derived growth factor receptor families. The stem cell factor (SCF) receptor, c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44c5b5024c401a59fa5a46c73f3831a5
https://doi.org/10.1182/blood.v97.5.1413
https://doi.org/10.1182/blood.v97.5.1413
Autor:
Anne-Marie, O'Farrell, James M, Foran, Walter, Fiedler, Hubert, Serve, Ron L, Paquette, Maureen A, Cooper, Helene A, Yuen, Sharianne G, Louie, Heidi, Kim, Susan, Nicholas, Michael C, Heinrich, Wolfgang E, Berdel, Carlo, Bello, Mark, Jacobs, Paul, Scigalla, William C, Manning, Stephen, Kelsey, Julie M, Cherrington
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 9(15)
Obtaining direct and rapid proof of molecular activity in early clinical trials is critical for optimal clinical development of novel targeted therapies. SU11248 is an oral multitargeted kinase inhibitor with selectivity for fms-related tyrosine kina
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5517d328627f89c5656dc799c721b9ca
https://pubmed.ncbi.nlm.nih.gov/14654525
https://pubmed.ncbi.nlm.nih.gov/14654525
Autor:
Julie M. Cherrington, Weiru Hong, Beverly Smolich, Anne Marie O'Farrell, Maher Albitar, Alison L. Hannah, Sharianne G. Louie, Alison Stopeck, Helene A. Yuen, Jeffrey E. Lancet, Lewis R. Silverman, Judith E. Karp, Francis J. Giles
Publikováno v:
Leukemia research. 28(7)
Acute myeloid leukemia (AML) is associated with dysregulated hematopoietic cell proliferation and increased bone marrow angiogenesis, each regulated by signaling through receptor tyrosine kinases (RTKs). SU5416 is a small molecule inhibitor of VEGF r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f21a2286f29b61385723bde84d13b3a
https://pubmed.ncbi.nlm.nih.gov/15158089
https://pubmed.ncbi.nlm.nih.gov/15158089